Compare ACOG & ONL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACOG | ONL |
|---|---|---|
| Founded | 2000 | 2021 |
| Country | Canada | United States |
| Employees | 71 | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.1M | 165.4M |
| IPO Year | N/A | 2021 |
| Metric | ACOG | ONL |
|---|---|---|
| Price | $8.34 | $2.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $16.00 | $3.00 |
| AVG Volume (30 Days) | 54.8K | ★ 618.5K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.83% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $147,647,000.00 |
| Revenue This Year | $139.22 | $4.10 |
| Revenue Next Year | $134.48 | $3.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.50 | $1.92 |
| 52 Week High | $10.59 | $3.04 |
| Indicator | ACOG | ONL |
|---|---|---|
| Relative Strength Index (RSI) | 70.71 | 35.98 |
| Support Level | $5.27 | $2.62 |
| Resistance Level | N/A | $2.66 |
| Average True Range (ATR) | 0.57 | 0.10 |
| MACD | 0.07 | -0.02 |
| Stochastic Oscillator | 82.05 | 9.09 |
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
Orion Properties Inc is an internally managed real estate investment trust engaged in the ownership, acquisition, and management of a diversified portfolio of office properties located in high-quality suburban markets across the United States and leased mainly on a single-tenant net lease basis to creditworthy tenants. Its portfolio is comprised of traditional office properties, as well as governmental, medical office, flex/laboratory, and R&D and flex/industrial properties. The company is focused on shifting its portfolio concentration over time away from traditional office properties, towards more dedicated use assets with specialized uses that include an office component. It operates in one business segment: commercial real estate.